Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain

被引:54
作者
Chan, RKW
Vale, WW
Sawchenko, PE
机构
[1] Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA
[2] Salk Inst Biol Studies, Clayton Fdn, Labs Peptide Biol, La Jolla, CA 92037 USA
关键词
Alzheimer's disease; corticotropin-releasing factor; CRF-binding protein; CRF receptors; c-fos; obesity;
D O I
10.1016/S0306-4522(00)00322-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The corticotropin-releasing factor-binding protein is distinct from known corticotropin-releasing factor receptors, but can bind the peptide and neutralize its biological actions. Recent interest has centered about the therapeutic potential of "ligand inhibitors" of binding protein action, synthetic corticotropin-releasing factor fragments which are inactive at corticotropin-releasing factor receptors, but can displace the peptide from the binding protein, thereby increasing levels of free corticotropin-releasing factor. To identify sites of action of such ligands, the distribution of Fos expression seen following intracerebroventricular administration of rat/human corticotropin-releasing factor(6-33) (5-50 mug) was charted in relation to corticotropin-releasing factor-binding protein and receptor expression. It was expected that Fos induction would mimic aspects of the distribution of the two known corticotropin-releasing factor receptors, but the far greater correspondence was seen with that of the binding protein itself. This included neurons in the isocortex, the olfactory system, amygdala and a number of discrete brainstem cell groups; many Fos-immunoreactive neurons in each were found to co-express corticotropin-releasing factor-binding protein messenger RNA. Subsets of activated neurons co-expressed Type 1 corticotropin-releasing factor receptor messenger RNA, though these were largely limited to cell groups that also express the corticotropin-releasing factor-binding protein, and where binding protein immunoreactivity and Type 1 receptor transcripts were found to co-exist. Responsive neurons displaying Type 2 corticotropin-releasing factor receptor message were seen reliably only in the lateral septal nucleus. These findings support only a limited capacity of the ligand inhibitor to activate neurons bearing corticotropin-releasing factor receptors. The more pervasive activation seen among neurons that express the corticotropin-releasing factor-binding protein may be indicative of an unexpected role for this protein in signaling by corticotropin-releasing factor-related peptides. (C) 2000 IBRO. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:115 / 129
页数:15
相关论文
共 52 条
[1]   ESTIMATION OF NUCLEAR POPULATION FROM MICROTOME SECTIONS [J].
ABERCROMBIE, M .
ANATOMICAL RECORD, 1946, 94 (02) :239-247
[2]   Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotropin-releasing hormone [J].
Asaba, K ;
Makino, S ;
Hashimoto, K .
BRAIN RESEARCH, 1998, 806 (01) :95-103
[3]   Modulatory actions of corticotropin-releasing factor-binding protein [J].
Behan, DP ;
DeSouza, EB ;
Potter, E ;
Sawchenko, P ;
Lowry, PJ ;
Vale, WW .
NEUROPEPTIDES: BASIC AND CLINICAL ADVANCES, 1996, 780 :81-95
[4]   DISPLACEMENT OF CORTICOTROPIN-RELEASING FACTOR FROM ITS BINDING-PROTEIN AS A POSSIBLE TREATMENT FOR ALZHEIMERS-DISEASE [J].
BEHAN, DP ;
HEINRICHS, SC ;
TRONCOSO, JC ;
LIU, XJ ;
KAWAS, CH ;
LING, N ;
DESOUZA, EB .
NATURE, 1995, 378 (6554) :284-287
[5]  
Behan DP, 1996, MOL PSYCHIATR, V1, P265
[6]   CORTICOTROPIN-RELEASING FACTOR (CRF) BINDING-PROTEIN - A NOVEL REGULATOR OF CRF AND RELATED PEPTIDES [J].
BEHAN, DP ;
DESOUZA, EB ;
LOWRY, PJ ;
POTTER, E ;
SAWCHENKO, P ;
VALE, WW .
FRONTIERS IN NEUROENDOCRINOLOGY, 1995, 16 (04) :362-382
[7]   Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system [J].
Bittencourt, JC ;
Sawchenko, PE .
JOURNAL OF NEUROSCIENCE, 2000, 20 (03) :1142-1156
[8]   CORTICOTROPIN RELEASING-FACTOR - CENTRAL-NERVOUS-SYSTEM SITES OF ACTION [J].
BROWN, M .
BRAIN RESEARCH, 1986, 399 (01) :10-14
[9]   Excess corticotropin releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice [J].
Burrows, HL ;
Nakajima, M ;
Lesh, JS ;
Goosens, KA ;
Samuelson, LC ;
Inui, A ;
Camper, SA ;
Seasholtz, AF .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07) :1439-1447
[10]  
Chan R. K. W., 1999, Society for Neuroscience Abstracts, V25, P155